March 02, 2020
A biotech company found liable for defaming a pharmaceutical executive aiming to gain control of it was denied a new trial Monday by a federal judge who said overwhelming evidence shows the company fabricated the North Carolina businessman's links to fraud.
March 19, 2019
A North Carolina federal jury has found that Puma Biotechnology Inc. defamed Pharmaceutical Product Development LLC's former CEO during a proxy fight by telling the public he had been "involved in clinical trial fraud," awarding the former PPD head $22.35 million.